The Misleading "Pooled Effect Estimate" of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19)
- PMID: 33201228
- PMCID: PMC7717230
- DOI: 10.1093/cid/ciaa1735
The Misleading "Pooled Effect Estimate" of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19)
Comment in
-
Reply to Tleyjeh.Clin Infect Dis. 2021 Jun 15;72(12):e1155-e1156. doi: 10.1093/cid/ciaa1736. Clin Infect Dis. 2021. PMID: 33340049 No abstract available.
Comment on
-
Decreased Mortality in Coronavirus Disease 2019 Patients Treated With Tocilizumab: A Rapid Systematic Review and Meta-analysis of Observational Studies.Clin Infect Dis. 2021 Jun 1;72(11):e742-e749. doi: 10.1093/cid/ciaa1445. Clin Infect Dis. 2021. PMID: 32964913 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical